Does Europe Need Shared Standards for Medical Cannabis?
Canify’s Silvia von Pistor will join a discussion on medicine quality and what happens when patients need to switch products.
The latest cannabis health, science and regulatory news from the UK and Europe.
Canify’s Silvia von Pistor will join a discussion on medicine quality and what happens when patients need to switch products.
Pain specialist Dr Michael Überall discusses cannabinoid-based medicines, opioids, and what meaningful improvement looks like for patients.
Pharmacist Nitin Makadia will discuss safer prescribing and lessons from European medical cannabis care at Frankfurt’s symposium on 4 November.
Ahead of Frankfurt’s Cannabis Health Symposium, Professor Bernd Werse discusses changing cannabis use and the evidence policymakers still need.
Lisa Katharina Haag will bring her perspective on cannabis policy and patient care to the one-day event.
Dr Julian Wichmann will discuss patient assessments, follow-up care and responsibility for treatment.
Professor Bernd Werse will join a debate examining the evidence behind cannabis policy on 4 November.
The pharmaceutical industry representative will examine treatment costs and what policy changes mean for patients.
Researchers in Scotland are testing CBD for endometriosis and the lasting effects of chemotherapy, while European back-pain trials have helped bring a cannabis medicine to market. Cannabis Health looks at the studies, their findings and what comes next.
Professor Sylvia Mechsner will examine the evidence for medical cannabis in women’s health on 4 November.
The European Medicinal Cannabis Association’s general secretary will join a debate on how research informs cannabis policy in less than two weeks time.
Families of patients with treatment-resistant epilepsy in the UK have received confirmation from a UK drug manufacturer that a six-month supply of Bedrolite is available. In an email sent to […]
Changes to Germany’s health insurance rules have left patients facing new limits on funded cannabis treatment. Cannabis Health explains the rules and the industry’s objections.
Upcoming Symposiums
Evidence-led education for clinicians, industry and patient advocates — across Europe.
Every ticket includes 12 months’ free MCCS membership — worth up to £120.
4 November 2026
Frankfurt · Mainhaus
26 November 2026
London · Conway Hall